[HTML][HTML] Organ System/Specialty
M Abdelghany - emdocs.net
A 65-year-old man is brought to the ED in shock. His vital signs include temperature 102 F,
heart rate 132 beats/minute, respiratory rate 36 breaths/minute, blood pressure 80/50 mm …
heart rate 132 beats/minute, respiratory rate 36 breaths/minute, blood pressure 80/50 mm …
[PDF][PDF] Comparison of the Difference in Nephrotoxicity between Nafcillin and Piperacillin-Tazobactam
SK Patel - 2016 - pdfs.semanticscholar.org
Comparison of the Difference in Nephrotoxicity between Nafcillin and Piperacillin-Tazobactam
Page 1 University of Kentucky UKnowledge Theses and Dissertations--Public Health (MPH & …
Page 1 University of Kentucky UKnowledge Theses and Dissertations--Public Health (MPH & …
Regulation of T Cells and Tissue Inflammation by Short Chain Fatty Acids
JH Park - 2016 - docs.lib.purdue.edu
Intestinal microbiota regulate various biological processes in the host. Intestinal microbiota
produce short chain fatty acids (SCFAs) via dietary fiber fermentation. SCFAs have profound …
produce short chain fatty acids (SCFAs) via dietary fiber fermentation. SCFAs have profound …
[PDF][PDF] Retrospective Evaluation of Acute Kidney Injury: Extended Infusion versus Standard Infusion Piperacillin/Tazobactam with Vancomycin
D Ratermann, M Sepulveda… - Journal of Pharmacy and …, 2014 - davidpublisher.com
Antibiotics cause 36 percent of all cases of drug-induced AKI (acute kidney injury). Research
suggests that drug-induced AKI increases hospital length of stay, ventilator days and …
suggests that drug-induced AKI increases hospital length of stay, ventilator days and …
[PDF][PDF] Piperacillin/tazobactam の副作用および相互作用に関する疫学研究
門村将太 - 2021 - eprints.lib.hokudai.ac.jp
NSAID Non-steroidal anti-inflammatory drug OAT Organic anion transporter PC Platelet
concentrate PIPC Piperacillin PIPC/TAZ Piperacillin/tazobactam PMDA Pharmaceuticals …
concentrate PIPC Piperacillin PIPC/TAZ Piperacillin/tazobactam PMDA Pharmaceuticals …
テイコプラニンとタゾバクタム/ピペラシリンの併用投与における腎機能への影響
松屋翔太， 川端俊介 - 日本環境感染学会誌, 2023 - jstage.jst.go.jp
抄録 近年, バンコマイシン (VCM) とタゾバクタム/ピペラシリン (TAZ/PIPC) の併用投与は急性腎
障害 (AKI) の発現率が上昇するという調査結果が多数報告されている. しかし, VCM の類薬である …
障害 (AKI) の発現率が上昇するという調査結果が多数報告されている. しかし, VCM の類薬である …
[引用][C] Piperasilin-Tazobaktam Preparatlarının Hastalarda Görülen Yan Etkiler Yönünden Karşılaştırılması
G Gürsoy - 2014 - Tıp Fakültesi